- Home
- AEON vs RETO Comparison
AEON vs RETO Comparison
Compare AEON & RETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEON
- RETO
- Stock Information
- Founded
- AEON N/A
- RETO 1999
- Country
- AEON United States
- RETO China
- Employees
- AEON N/A
- RETO N/A
- Industry
- AEON Biotechnology: Pharmaceutical Preparations
- RETO Multi-Sector Companies
- Sector
- AEON Health Care
- RETO Consumer Discretionary
- Exchange
- AEON Nasdaq
- RETO Nasdaq
- Market Cap
- AEON 21.6M
- RETO 19.9M
- IPO Year
- AEON N/A
- RETO 2017
- Fundamental
- Price
- AEON $0.15
- RETO $0.91
- Analyst Decision
- AEON Strong Buy
- RETO
- Analyst Count
- AEON 1
- RETO 0
- Target Price
- AEON $5.00
- RETO N/A
- AVG Volume (30 Days)
- AEON 45.9M
- RETO 16.2K
- Earning Date
- AEON 11-13-2024
- RETO 10-28-2024
- Dividend Yield
- AEON N/A
- RETO N/A
- EPS Growth
- AEON N/A
- RETO N/A
- EPS
- AEON 0.34
- RETO N/A
- Revenue
- AEON N/A
- RETO $3,841,142.00
- Revenue This Year
- AEON N/A
- RETO N/A
- Revenue Next Year
- AEON N/A
- RETO N/A
- P/E Ratio
- AEON $0.45
- RETO N/A
- Revenue Growth
- AEON N/A
- RETO N/A
- 52 Week Low
- AEON $0.10
- RETO $0.84
- 52 Week High
- AEON $17.17
- RETO $5.00
- Technical
- Relative Strength Index (RSI)
- AEON 27.61
- RETO 47.58
- Support Level
- AEON $0.10
- RETO $0.84
- Resistance Level
- AEON $0.22
- RETO $0.92
- Average True Range (ATR)
- AEON 0.05
- RETO 0.05
- MACD
- AEON -0.02
- RETO 0.00
- Stochastic Oscillator
- AEON 10.04
- RETO 64.60
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
About RETO ReTo Eco-Solutions Inc.
ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.